Meet enFuse^®

enFuse is an innovative, wearable drug delivery platform designed to comfortably and conveniently deliver large volumes of medications subcutaneously. Featuring hands-free wearable technology, patients receive their needed treatment in a simple injection under the skin, instead of intravenously.

Recognized by leading industry publications such as Fierce Pharma and PM360, the enFuse has been presented with awards honoring our novel technology, business growth, and focus on the patient experience.

About Us

We are a healthcare innovation company committed to improving the patient treatment experience through the development and manufacturing of our enFuse wearable drug delivery platform.

Current Partnerships

Enable is working with a number of pharma partners to conduct clinical trials and plan for joint commercial launch of partnered therapies in combination with enFuse.

Patients love enFuse

I can have a painless experience. It’s been simpler and psychologically liberating. The Injector has allowed me to reclaim my passions and continue work on my life project. -Robert, EMPAVELI Injector Patient

The Injector gave me my life back and allowed me to not worry constantly. I can enjoy life. -Cathy, EMPAVELI Injector Patient

Freedom and endless possibilities. I can have it on me and go do what I need to do. Having the Injector is psychologically freeing. I no longer dread taking the medication. -Tonya, EMPAVELI Injector Patient

Recent News

January 9, 2025

New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

September 12, 2024

Enable Injections Announces Agreement with Sobi to Develop and Distribute Aspaveli in Combination with enFuse in Sobi Territories

May 22, 2024

Enable Injections Names Matthew Huddleston as Chief Commercial Officer

Sign Up For Our Newsletter

Stay up to date on the latest enFuse technology, partnerships, events, and news by signing up to receive the once-monthly Enable Injections Newsletter direct to your inbox.